kwic
compared+to
compared+to
right
on
off
162
1
100
500
strict
ELIZA cgi-bash version rev. 1.90
- Medical English LInking keywords finder for the PubMed Zipped Archive (ELIZA) -
return
kwic search for compared to out of >500 occurrences
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [no cache] 500 found
[frequency of next (right) word to compared to]
270181 occurrences (No.97 in the rank) during 5 years in the PubMed. [no cache] 500 found
| 162) release of Cu B from nanoscale CCS-films compared to that from a conventional CCS f |
| 163) e contralateral side in the control group compared to that in the BoTA group (P < |
| 164) 7, and eNOS phosphorylation at Thr495, as compared to that in the control. |
| 165) es both showed a lower-level distribution compared to that in the plasma, which indi |
| 166) use calvarial defect model over 4 weeks compared to that in the untreated group. |
| 167) e pattern accounting for 20% drug release compared to that of OP solution up to 90% |
| 168) in female Turkish immigrants is higher as compared to that of native-born women of t |
| 169) bosomal gene was amplified, sequenced and compared to that of other diplozoid taxa. |
| 170) ein formulations, and its stabilizing was compared to that of other excipients which |
| 171) ngement of cox2-rrnS in F-type mitogenome compared to that of other freshwater musse |
| 172) ding 1.0 mg/ml of the UE + HPE extract compared to that of the control (no treatm |
| 173) to increase the rate of the drug release compared to that of the free drug. |
| 174) Compared to controls at this stage, exposu |
| 175) s of animals exposed to d-phenothrin when compared to controls. |
| 176) of wound contraction and reepithelisation compared to controls. |
| 177) luteinising hormone (LH) in HCD group as compared to controls. |
| 178) voxel-wise morphometry in PG subjects as compared to controls. |
| 179) D was reduced in CHD patients (P<0.05) compared to controls. |
| 180) novel learning of spatial configurations compared to controls. |
| 181) wer at each sampling time post-activation compared to controls. |
| 182) re highly expressed in hemangioma samples compared to controls. |
| 183) ntents at various stages of wound healing compared to controls. |
| 184) re were more likely to be innovators when compared to other centrally-located PCAs, |
| 185) a lower rate of graft versus host disease compared to other donor sources. |
| 186) he weakest intentions to report rape when compared to other ethnic groups, cultural |
| 187) elevated risk for depression and suicide compared to other ethnic groups. |
| 188) splatin-loaded targeted-nanogel treatment compared to other formulations. |
| 189) decreased significantly in the SFNC group compared to other groups (p<0.05). |
| 190) ontrolled statistically when the IPDS was compared to other measures of psychopathol |
| 191) berculosis infection (LTBI) treatment, as compared to other referral groups, and to |
| 192) (0.02) and it was very low (0.011), when compared to other species of Gallus. |
| 193) ad significantly lower risk-adjusted rate compared to other surgical inpatients for |
| 194) in patients with systemic sclerosis (SSc) compared to healthy controls by measuring |
[
right
kwic]
(1)105  the |
(10)6 conventional |
(19)3 group |
(28)2 groups |
| (2)23 those |
(11)5 controls, |
(20)3 pure |
(29)2 its |
| (3)19 control |
(12)5 placebo |
(21)2 TCDD |
(30)2 long |
| (4)14 a |
(13)5 untreated |
(22)2 age-matched |
(31)2 non-Hispanic |
| (5)12 that |
(14)4 Exo(Normoxic) |
(23)2 baseline |
(32)2 non-transgenic |
| (6)10 controls |
(15)4 all |
(24)2 bur-prepared |
(33)2 people |
| (7)10 other |
(16)4 patients |
(25)2 children |
(34)2 plain |
| (8)9 healthy |
(17)3 an |
(26)2 controls), |
(35)2 previous |
| (9)9 their |
(18)3 drug |
(27)2 experimental |
(36)2 vehicle |
add keyword
--- WordNet output for compared ---